L-NAME hydrochloride |
2356-100 |
Biovision |
each |
EUR 144 |
Human IgG antibody Laboratories manufactures the (lee biosolutions reagents distributed by Genprice. The (Lee Biosolutions reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact . Other (Lee products are available in stock. Specificity: (Lee Category: Biosolutions
JBS True Blue |
MiTeGen |
300 µl |
EUR 16 |
Description: JBS True Blue |
B / Lee / 40 Strain Protein |
Abbexa |
1 ml |
EUR 1228.8 |
|
Index Name Not Yet Assigned |
Abbexa |
-
EUR 5204.40
-
EUR 1095.60
-
EUR 326.40
-
EUR 1914.00
-
EUR 710.40
|
|
|
Human True insulin ELISA kit |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Chemicals information
LEE011 |
A8641-10 |
ApexBio |
10 mg |
EUR 226.8 |
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2]. |
LEE011 |
A8641-25 |
ApexBio |
25 mg |
EUR 338.4 |
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2]. |
LEE011 |
A8641-5 |
ApexBio |
5 mg |
EUR 170.4 |
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2]. |
LEE011 |
A8641-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 181.2 |
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2]. |
LEE011 |
A8641-50 |
ApexBio |
50 mg |
EUR 408 |
Description: LEE011 (NVP-LEE011) is a highly specific inhibitor of CDK4/CDK6 and functions via decreasing in phosphorylated RB and FOXM1 [1]. When tested with 17 human neuroblastoma cell lines, 12 of them were sensitive to LEE011 treatment with mean IC50=306±68 nM [2]. |
LEE011 succinate |
B1084-10 |
ApexBio |
10 mg |
EUR 200.4 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-100 |
ApexBio |
100 mg |
EUR 420 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-200 |
ApexBio |
200 mg |
EUR 640.8 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-5 |
ApexBio |
5 mg |
EUR 160.8 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 192 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-50 |
ApexBio |
50 mg |
EUR 300 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |
LEE011 succinate |
B1084-500 |
ApexBio |
500 mg |
EUR 1101.6 |
Description: LEE011 succinate is an orally available cyclin-dependent kinase (CDK) inhibitor targeting cyclin D1/CDK4 and cyclin D3/CDK6 cell cycle pathway, with potential antineoplastic activity. |